PCM
STJ

Penserra Capital Management’s St Jude Medical STJ Stock Holding History

Penserra Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,451
Closed -$918K – 957
2016
Q4 		$918K Buy
11,451
+2,258
+25% +$179K 0.1% 97
2016
Q3 		$733K Buy
+9,193
New +$742K 0.09% 81

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Penserra Capital Management's STJ Position: Q1 2017 in Review

Penserra Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 11,451 shares — an estimated $918K sold.

Penserra Capital Management first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $918K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Penserra Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Penserra Capital Management sold 11,451 St Jude Medical shares in Q1 2017, an estimated $918K.
  • Penserra Capital Management first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Penserra Capital Management's St Jude Medical position peaked at $918K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Penserra Capital Management's 13F filing for Q1 2017, filed 9 May 2017.